Invesco · 2006-10-12 成立 · 规模、费率、NAV、资金流、完整持仓和风险收益使用各自可追溯公开源。
| 日期 | 估算净流 | 申购 / 销售 | 赎回 | 净资产 | 口径 |
|---|---|---|---|---|---|
| 2026-07-31 | -$5.2M | — | — | $135.4M | 每日估算 |
| 2026-07-27 | +$34.5M | — | — | $168.1M | 每日估算 |
| 2026-07-26 | -$30.3M | — | — | $135.4M | 每日估算 |
| 2026-04-30 | -$1.0M | $0 | $1.0M | $120.9M | SEC 月度 |
| 2026-03-31 | -$3.3M | $0 | $3.3M | — |
| 持仓 | 资产类别 | 数量 | 市值 | 权重 |
|---|---|---|---|---|
Invesco Private Prime Fund Invesco Private Prime Fund | STIV | 27,706,338 | $27.7M | 22.92% |
Invesco Private Government Fund Invesco Private Government Fund | STIV | 10,675,160 | $10.7M | 8.83% |
Praxis Precision Medicines, Inc. Praxis Precision Medicines, Inc. | EC | 19,267 | $6.1M | 5.08% |
Roivant Sciences Ltd. |
行情与风险截至 2026-07-30；NAV 的发布时间可能和交易所收盘错位。完整持仓是延迟监管披露，不代表当前盘中组合。
已使用：nasdaq_etf_screener、yahoo_chart、yahoo_quote_summary、sec_nport。缺口标记：nav_timestamp_unverified。
| SEC 月度 |
| 2026-02-28 | -$1.5M | $0 | $1.5M | — | SEC 月度 |
| EC |
| 197,099 |
| $5.6M |
| 4.65% |
United Therapeutics Corp. United Therapeutics Corp. | EC | 7,268 | $4.2M | 3.43% |
Tenet Healthcare Corp. Tenet Healthcare Corp. | EC | 20,745 | $3.7M | 3.04% |
Terns Pharmaceuticals, Inc. Terns Pharmaceuticals, Inc. | EC | 65,368 | $3.5M | 2.86% |
Tango Therapeutics Inc. Tango Therapeutics Inc. | EC | 159,490 | $3.4M | 2.85% |
HCA Healthcare, Inc. HCA Healthcare, Inc. | EC | 7,728 | $3.4M | 2.78% |
Axsome Therapeutics, Inc. Axsome Therapeutics, Inc. | EC | 15,385 | $3.2M | 2.64% |
Nektar Therapeutics Nektar Therapeutics | EC | 36,570 | $3.1M | 2.57% |
Celcuity Inc. Celcuity Inc. | EC | 25,182 | $3.1M | 2.53% |
Ionis Pharmaceuticals, Inc. Ionis Pharmaceuticals, Inc. | EC | 38,394 | $2.9M | 2.37% |
Capricor Therapeutics, Inc. Capricor Therapeutics, Inc. | EC | 81,402 | $2.7M | 2.26% |
Cencora, Inc. Cencora, Inc. | EC | 8,829 | $2.7M | 2.25% |
Alumis Inc. Alumis Inc. | EC | 103,872 | $2.6M | 2.12% |
Gilead Sciences, Inc. Gilead Sciences, Inc. | EC | 18,363 | $2.4M | 1.99% |
Kodiak Sciences Inc. Kodiak Sciences Inc. | EC | 55,223 | $2.4M | 1.99% |
BrightSpring Health Services, Inc. BrightSpring Health Services, Inc. | EC | 49,825 | $2.4M | 1.98% |
Jazz Pharmaceuticals PLC Jazz Pharmaceuticals PLC | EC | 11,426 | $2.3M | 1.92% |
Moderna, Inc. Moderna, Inc. | EC | 50,080 | $2.3M | 1.90% |
Protagonist Therapeutics, Inc. Protagonist Therapeutics, Inc. | EC | 23,165 | $2.3M | 1.90% |
Viatris Inc. Viatris Inc. | EC | 152,008 | $2.3M | 1.88% |
Dianthus Therapeutics, Inc. Dianthus Therapeutics, Inc. | EC | 24,726 | $2.2M | 1.80% |
AnaptysBio, Inc. AnaptysBio, Inc. | EC | 32,708 | $2.1M | 1.78% |
Ensign Group, Inc. (The) Ensign Group, Inc. (The) | EC | 11,223 | $2.1M | 1.73% |
Incyte Corp. Incyte Corp. | EC | 21,763 | $2.1M | 1.71% |
Erasca, Inc. Erasca, Inc. | EC | 194,096 | $2.1M | 1.71% |
Ligand Pharmaceuticals Inc. Ligand Pharmaceuticals Inc. | EC | 8,520 | $2.0M | 1.62% |
Oruka Therapeutics, Inc. Oruka Therapeutics, Inc. | EC | 28,323 | $1.9M | 1.60% |
CG Oncology, Inc. CG Oncology, Inc. | EC | 28,115 | $1.9M | 1.55% |
Tyra Biosciences, Inc. Tyra Biosciences, Inc. | EC | 53,591 | $1.9M | 1.54% |
SELLAS Life Sciences Group, Inc. SELLAS Life Sciences Group, Inc. | EC | 367,216 | $1.8M | 1.50% |
Spyre Therapeutics, Inc. Spyre Therapeutics, Inc. | EC | 24,120 | $1.8M | 1.49% |
Kymera Therapeutics, Inc. Kymera Therapeutics, Inc. | EC | 21,835 | $1.8M | 1.46% |
Twist Bioscience Corp. Twist Bioscience Corp. | EC | 30,064 | $1.8M | 1.45% |
Liquidia Corp. Liquidia Corp. | EC | 43,673 | $1.7M | 1.42% |
Brookdale Senior Living Inc. Brookdale Senior Living Inc. | EC | 118,923 | $1.7M | 1.41% |
Axogen, Inc. Axogen, Inc. | EC | 38,310 | $1.7M | 1.37% |
Exelixis, Inc. Exelixis, Inc. | EC | 36,251 | $1.6M | 1.33% |
Edgewise Therapeutics, Inc. Edgewise Therapeutics, Inc. | EC | 51,209 | $1.6M | 1.31% |
Trevi Therapeutics, Inc. Trevi Therapeutics, Inc. | EC | 114,114 | $1.6M | 1.30% |
Cytokinetics, Inc. Cytokinetics, Inc. | EC | 22,459 | $1.4M | 1.19% |
Elanco Animal Health Inc. Elanco Animal Health Inc. | EC | 62,951 | $1.4M | 1.16% |
Relay Therapeutics, Inc. Relay Therapeutics, Inc. | EC | 105,574 | $1.4M | 1.13% |
Dyne Therapeutics, Inc. Dyne Therapeutics, Inc. | EC | 77,358 | $1.4M | 1.12% |
Vaxcyte, Inc. Vaxcyte, Inc. | EC | 23,663 | $1.4M | 1.12% |
Krystal Biotech, Inc. Krystal Biotech, Inc. | EC | 5,073 | $1.3M | 1.10% |
Enliven Therapeutics, Inc. Enliven Therapeutics, Inc. | EC | 31,343 | $1.3M | 1.07% |
Arcus Biosciences, Inc. Arcus Biosciences, Inc. | EC | 44,685 | $1.1M | 0.94% |
Annexon, Inc. Annexon, Inc. | EC | 188,931 | $1.1M | 0.92% |
Stoke Therapeutics, Inc. Stoke Therapeutics, Inc. | EC | 33,715 | $1.1M | 0.91% |
Phibro Animal Health Corp., Class A Phibro Animal Health Corp., Class A | EC | 20,545 | $1.1M | 0.90% |
MoonLake Immunotherapeutics MoonLake Immunotherapeutics | EC | 58,091 | $951,531 | 0.79% |
BioAge Labs, Inc. BioAge Labs, Inc. | EC | 55,347 | $932,597 | 0.77% |
Syndax Pharmaceuticals, Inc. Syndax Pharmaceuticals, Inc. | EC | 41,013 | $878,909 | 0.73% |
Perspective Therapeutics Inc. Perspective Therapeutics Inc. | EC | 207,471 | $809,137 | 0.67% |
Zenas Biopharma, Inc. Zenas Biopharma, Inc. | EC | 39,681 | $766,637 | 0.63% |
Viridian Therapeutics, Inc. Viridian Therapeutics, Inc. | EC | 52,099 | $702,295 | 0.58% |
Maze Therapeutics, Inc. Maze Therapeutics, Inc. | EC | 23,066 | $613,094 | 0.51% |
Invesco Government & Agency Portfolio, Institutional Class Invesco Government & Agency Portfolio, Institutional Class | STIV | 322,236 | $322,236 | 0.27% |